Healthcare >> CEO Interviews >> April 6, 2005

Philip Coelho – Thermogenesis Corporation (kool)

PHILIP H. COELHO has been Chairman and Chief Executive Officer of ThermoGenesis Corp. since November 1997. From December 1989 to November 1997, Mr. Coelho was President and CEO and from December 1986 to December 1989, he was Vice President of Research and Development. Mr. Coelho has been in the senior management of high technology consumer electronic or medical device companies for 30 years. He obtained a BS degree in Thermodynamic and Mechanical Engineering from the University of California, Davis. He is a member of the Society of Cryobiology and the inventor or co-inventor of 20 patents in the fields of cell cryobiology, robotics, and methods of isolating and harvesting wound healing proteins and enzymes from blood. Mr. Coelho is also a member of the Board of Directors of Mediware Information Systems, Lenexa, KS and Catalyst Pharmaceutical Partners, Coral Gables, Florida. Mr. Coelho initiated and led the recent lobbying effort in Congress to establish and finance a National Cord Blood Stem Cell Program which would collect 150,000 units of ethnically diverse, HLA typed, cryopreserved cord blood stem cell units for the on-demand treatment of patients in need of hematopoietic reconstitution---predominately patients with the hematological cancers of leukemia and lymphoma and genetic diseases such as sickle cell anemia, thalassemia and immune deficiencies. Profile
TWST: Could we begin with a brief historical sketch of Thermogenesis

Corporation and a picture of things as they are now?

Mr. Coelho: The company is a manufacturer of automated devices